Standard
Antipsychotic maintenance treatment versus dose reduction : how the story continues. / Sommer, Iris E.C.; Horowitz, Mark; Allott, Kelly; Speyer, Helene; Begemann, Marieke J.H.
In:
The Lancet Psychiatry, Vol. 9, No. 8, 2022, p. 602-603.
Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
Sommer, IEC, Horowitz, M, Allott, K
, Speyer, H & Begemann, MJH 2022, '
Antipsychotic maintenance treatment versus dose reduction: how the story continues',
The Lancet Psychiatry, vol. 9, no. 8, pp. 602-603.
https://doi.org/10.1016/S2215-0366(22)00230-9APA
Sommer, I. E. C., Horowitz, M., Allott, K.
, Speyer, H., & Begemann, M. J. H. (2022).
Antipsychotic maintenance treatment versus dose reduction: how the story continues.
The Lancet Psychiatry,
9(8), 602-603.
https://doi.org/10.1016/S2215-0366(22)00230-9Vancouver
Sommer IEC, Horowitz M, Allott K
, Speyer H, Begemann MJH.
Antipsychotic maintenance treatment versus dose reduction: how the story continues.
The Lancet Psychiatry. 2022;9(8):602-603.
https://doi.org/10.1016/S2215-0366(22)00230-9Author
Sommer, Iris E.C. ; Horowitz, Mark ; Allott, Kelly ; Speyer, Helene ; Begemann, Marieke J.H. / Antipsychotic maintenance treatment versus dose reduction : how the story continues. In: The Lancet Psychiatry. 2022 ; Vol. 9, No. 8. pp. 602-603.
Bibtex
@article{cf9fedeb39f54e00b730d7cbf32622eb,
title = "Antipsychotic maintenance treatment versus dose reduction: how the story continues",
author = "Sommer, {Iris E.C.} and Mark Horowitz and Kelly Allott and Helene Speyer and Begemann, {Marieke J.H.}",
note = "Funding Information: KA declares a Career Development Fellowship from the National Health and Medical Research Council of Australia which supports her salary to conduct independent research. All other authors have no competing interests.",
year = "2022",
doi = "10.1016/S2215-0366(22)00230-9",
language = "English",
volume = "9",
pages = "602--603",
journal = "The Lancet Psychiatry",
issn = "2215-0366",
publisher = "TheLancet Publishing Group",
number = "8",
}
RIS
TY - JOUR
T1 - Antipsychotic maintenance treatment versus dose reduction
T2 - how the story continues
AU - Sommer, Iris E.C.
AU - Horowitz, Mark
AU - Allott, Kelly
AU - Speyer, Helene
AU - Begemann, Marieke J.H.
N1 - Funding Information:
KA declares a Career Development Fellowship from the National Health and Medical Research Council of Australia which supports her salary to conduct independent research. All other authors have no competing interests.
PY - 2022
Y1 - 2022
U2 - 10.1016/S2215-0366(22)00230-9
DO - 10.1016/S2215-0366(22)00230-9
M3 - Comment/debate
C2 - 35753324
AN - SCOPUS:85134350785
VL - 9
SP - 602
EP - 603
JO - The Lancet Psychiatry
JF - The Lancet Psychiatry
SN - 2215-0366
IS - 8
ER -
